{{Rsnum
|rsid=3791850
|Gene=GAD1
|Chromosome=2
|position=170851590
|Orientation=plus
|GMAF=0.1593
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GAD1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 68.1 | 26.5 | 5.3
| HCB | 86.1 | 13.9 | 0.0
| JPT | 83.2 | 15.9 | 0.9
| YRI | 76.2 | 22.4 | 1.4
| ASW | 71.9 | 26.3 | 1.8
| CHB | 86.1 | 13.9 | 0.0
| CHD | 88.1 | 11.0 | 0.9
| GIH | 77.2 | 22.8 | 0.0
| LWK | 82.7 | 17.3 | 0.0
| MEX | 70.7 | 24.1 | 5.2
| MKK | 68.6 | 28.2 | 3.2
| TSI | 48.0 | 48.0 | 3.9
| HapMapRevision=28
}}Association between glutamic acid decarboxylase genes and [[anxiety]] disorders, major [[depression]], and [[neuroticism]].{{PMID|16718280}}

{{PMID|19111404|OA=1
}} Associations of glutamate decarboxylase genes with initial sensitivity and age-at-onset of alcohol dependence in the Irish Affected Sib Pair Study of Alcohol Dependence.

{{PMID|19500151|OA=1
}} Heroin addiction in African Americans: a hypothesis-driven association study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}